On Thursday, Starboard Value LP, a significant shareholder of Pfizer Inc. (NYSE:PFE), issued a letter to the company’s Board of Directors.
Starboard Value said they had scheduled a meeting with CEO Albert Bourla, Shantanu Narayen, and potentially other Board members on October 16. They plan to share their perspectives and discuss Pfizer’s future direction.
The letter highlights recent press reports that Starboard reached out to the company’s former CEO, Ian Read, and former CFO, Frank D’Amelio, as part of their due diligence process.
Both Mr. Read and Mr. D’Amelio expressed concerns regarding Pfizer’s current trajectory. As former executives ...